Good Clinical

Today’s guest is Will Charles, the Executive Director of Investment at UniServices. This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ UUniversities are a great place to get higher education, but they're also places where new ideas, concepts and technologies first take root. But how do new ideas make their way from the academic setting to the commercial...

Today’s guest is Dr Rohit Katial, a Research Physician involved in Early Phase Clinical Trials in New Zealand. This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ Unfortunately, in New Zealand our access to modern medicines is well behind our OECD peers, and it typically takes 10 years before a new medicine is funded by Pharmac after being approved by Med...

Today’s guest is Shamubeel Eaqub, and economist, author and commentator.  This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ In this episode Shamubeel and I discuss New Zealands productivity has not kept up with our OECD peers. Reasons for this include some things we cannot change, such as the fundamental realities of our small population and remote loca...

Today’s guest is Natalia Lopez, the Co-Founder and Chief Operations Officer of Kitea Health.  This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ I n our first episode of 2024, we are picking up where we left of in 2023 with another guest from Kitea Health - this time with Chief Operations Officer Natalia Lopez. We talk about Natalia's journey from the au...

This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ Today’s guest is Dr Simon Malpas, the Co-founder and CEO of Kitea Health. Simon is a distinguished New Zealand scientist and entrepreneur, and has co-founded three successful medical device & life science companies from his research, including Kitea Health, a Start up company transforming healthcare...

This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ Dr Chris Wynne is the Chief Scientific Officer at New Zealand Clinical Research (NZCR). Chris has had a career of giant proportions in Clinical Research, and has been involved in a wide range of trials, including the early trials that laid the groundwork for the function cure of Hepatits C, down to the P...

This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/ Courtney Rowse is the Clinical Operations Manager for MSD (ANZ). Clinical Research is one of those industries where most people get into it by accident. There are no consistent pathways into the industry, in fact if you were to sample 100 people, the only consistency would be inconsistency. Join us for E...

Kieran Jina is Partner at Pacific Channel, a Venture Capital firm focusing on start-up companies using breakthrough science and advanced engineering to seucure the future of Health, Environment and Food, aka "Deep Tech". Their second Fund "Pacific Channel Fund II" is the largest fund of its type and sector in New Zealand. Venture Capital has a certain mystique to it. What does a Venture Capitalist...

Dr Diana Siew is the Strategic Partnerships Lead for the Bioengineering Institute and the Co-Founder of the Consortium for Medical Device Technologies (CMDT). Twelve years ago, there was not much in the way high-value Medical Research commercialization - publicly-funded research was sitting idle, and international companies were bypassing New Zealand in favor of other countries. Dr Siew has been p...

Hanie Yee is the COO of Alimetry, a New Zealand-based MedTech company developing a device for the non-invasive diagnosis of gastric disorders; as well as the Investment Committee Chair for the Return on Science MedTech and Surgery Investment Committee. Hanie began her career in Clinical Research and worked with some of the big names in the industry including Genetech and Takeda, before moving to F...

Julie Jones is the Founder and CEO of BioValeo, a New Zealand-based Contract Research Organization (CRO) providing services to companies developing Precision or Personalized Medicine Interventions. As medicine progresses, treatments are becoming more specific and tailored to the individual patient. Rather than bundling patients according to a high-level disease category, next generation treatments...

Prof Greg O'Grady is a Professor of Surgery and the CEO of Alimetry, a New Zealand-based MedTech company developing a device for the non-invasive diagnosis of gastric disorders, such as neuromuscular dysfunction, Gut-brain disorder, Gastric Outlet Disease, to name a few. Greg's career is truly impressive, and with each rung he has climbed, the scale of the impact he can effect has increased. As a...

Dr Ed Watson is the CEO of Aotearoa Clinical Trials, a network of hospital based clinical trial sites with over 20 years experience in clinical trials in Aotearoa - New Zealand. While it is well understood that Clinical Research plays a crucial role in advancing medical knowledge, and developing new therapies, we need to also recognize that it also contributes to the reduction of Health Inequities...

Kris Vette is the Founder and CEO of Genecrypt, a platofmr providing end-to-end encryption of genomic data. As technology advances, we can expect genetic data to be used more frequently in both research and clinical settings. The promise of Precision medicine is we could use our unique genetic fingerprints inform healthcare decisions, and thus get the most out of our health, whether it be treatmen...

Dr Malvindar Singh-Bains' is a Research Fellow at the University of Auckland Centre for Brain Research, and her work is contributing to a paradigm shift in the way we investigate Neurodegenerative disease and design future treatments. One of Malvindar's areas of research is Huntington's Disease (HD), a neurodegenerative disease characterized by the accumulation of a mutated version of the aptly-na...

Dr Sarah Diermeier is a pioneer in the world of RNA therapeutics. Armed with a PhD, she completed a post-doctoral research fellowship at the prestigious Cold Spring Harbour Laboratory in Long Island New York, before re-locating to New Zealand with her family to take up a tenured role at Otago University and founding Amaroq Therapeutics. Amaroq is a Venture-backed, pre-clinical, biotech start-up le...

Abbas Al-Murrani is a Health Economist and the Managing Director of Health Economist Consulting NZ. In this episode of Chat_GCP we explore why upfront costs are not the be all and end all, the importance of values in decision-making, and hear Abbas' take on why we need more Health Economists in New Zealand. You can find Abbas here: https://www.linkedin.com/in/abbasalmurrani/ http://www.hec.nz/